Mirk/Dyrk1B modulates the development of chemoresistance in human ovarian cancer.

被引：0
|
作者：
Gao, Jingchun [1 ]
Li, Ji [1 ]
Gao, Heli [2 ]
Tian, Jianxin [1 ]
Lv, Yunyi [1 ]
Yang, Zhihai [1 ]
Zhang, Qiuping [2 ]
Kong, Fandou [1 ]
Pang, Jian [1 ]
Guan, Hongwei [2 ]
Shi, Hong [1 ]
机构：
[1] Dalian Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Dalian, Liaoning, Peoples R China
[2] Dalian Med Univ, Affiliated Hosp 1, Dept Pathol, Dalian, Liaoning, Peoples R China
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3376
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3376
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mirk/dyrk1B Kinase in Ovarian Cancer
    Friedman, Eileen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (03): : 5560 - 5575
  • [2] Mirk/Dyrk1B in cancer
    Friedman, Eileen
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (02) : 274 - 279
  • [3] The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer
    Gao, Jingchun
    Yang, Xiangjun
    Yin, Ping
    Hu, Wenfeng
    Liao, Hongfeng
    Miao, Zhihui
    Pan, Chao
    Li, Na
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (04) : 1203 - 1209
  • [4] Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition
    Hu, Jing
    Deng, Holly
    Friedman, Eileen A.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (10) : 2258 - 2269
  • [5] Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy
    Kokkorakis, Nikolaos
    Zouridakis, Marios
    Gaitanou, Maria
    PHARMACEUTICS, 2024, 16 (04)
  • [6] Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas
    Mercer, Stephen E.
    Ewton, Daina Z.
    Shah, Sejal
    Naqvi, Asghar
    Friedman, Eileen
    CANCER RESEARCH, 2006, 66 (10) : 5143 - 5150
  • [7] Implication of DYRK1B Kinase in ovarian cancers and utilization of DYRK1B Inhibitors as a novel therapeutic strategy for ovarian cancer
    Kuznetsova, Alexandra
    Damiani, Arianna
    De Leon, Lita
    Frid, Michael
    Duey, Menelik
    Law, Jason
    Potapova, Olga
    Vilenchik, Maria
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells
    Ewton, Daina Z.
    Hu, Jing
    Vilenchik, Maria
    Deng, Xiaobing
    Luk, Kin-chun
    Polonskaia, Ann
    Hoffman, Ann F.
    Zipf, Karen
    Boylan, John F.
    Friedman, Eileen A.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (11) : 2104 - 2114
  • [9] Mirk/dyrk1B kinase is upregulated following inhibition of mTOR
    Deng, Xiaobing
    Hu, Jing
    Ewton, Daina Z.
    Friedman, Eileen
    CARCINOGENESIS, 2014, 35 (09) : 1968 - 1976
  • [10] Mirk/Dyrk1B controls ventral spinal cord development via Shh pathway
    Kokkorakis, N.
    Douka, K.
    Nalmpanti, A.
    Politis, P. K.
    Zagoraiou, L.
    Matsas, R.
    Gaitanou, M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
12345